Cough and Congestion Relief with Guaifenesin and Codeine
Introduction to Cough Suppression and Expectorants
- Codeine is an opioid cough suppressant that acts centrally to suppress the cough reflex, with a standard adult dosing range of 30-60 mg every 4-6 hours (maximum 240 mg in 24 hours), as recommended by the American Thoracic Society 1, 2
- Guaifenesin is an expectorant that helps loosen phlegm and bronchial secretions, with a mechanism of action that involves increasing the amount of water in the airways and reducing the viscosity of mucus, as described by the American Academy of Allergy, Asthma, and Immunology 4
Dosing and Administration
- The standard dosing for guaifenesin with codeine is not explicitly stated, but the codeine component is typically dosed at 10-20 mg per dose, with a maximum daily dose of 40 mL (80 mg codeine/800 mg guaifenesin) 1
- Short-term use only (typically 5-7 days) is recommended, with reassessment if symptoms persist beyond one week, as suggested by the American College of Physicians 3, 6
Safety and Efficacy Considerations
- Codeine may cause drowsiness, constipation, and respiratory depression at higher doses, with a risk of dependence and overdose, as warned by the National Institute for Health and Care Excellence 1, 3
- Guaifenesin is generally well-tolerated with minimal side effects at recommended doses, but may interact with other CNS depressants, as noted by the British Medical Journal 2
- Avoid in patients with chronic bronchitis and bronchiectasis as cough suppressants can cause sputum retention, as advised by the European Respiratory Society 2